Chargement en cours...
Assessment of In Vivo and In Vitro Genotoxicity of Glibenclamide in Eukaryotic Cells
Glibenclamide is an oral hypoglycemic drug commonly prescribed for the treatment of type 2 diabetes mellitus, whose anti-tumor activity has been recently described in several human cancer cells. The mutagenic potential of such an antidiabetic drug and its recombinogenic activity in eukaryotic cells...
Enregistré dans:
| Publié dans: | PLoS One |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Public Library of Science
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4372363/ https://ncbi.nlm.nih.gov/pubmed/25803314 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0120675 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|